Research has revealed Australians significantly underestimate the role of family history in developing macular degeneration.
Macular Degeneration Foundation believes a cap on the Medicare item number for the treatment of wet AMD should have minimal impact on patients.
The TGA has approved a new drug, Eylea, for the treatment of wet (neovascular) age-related macular degeneration.
ABC to trial audio description on television to assist people who are blind or visually impaired.
Dame Judi Dench has revealed a diagnosis of age-related macular degeneration.
The federal government has heard and acknowledged the Foundation’s postcard campaign for increased funding.
We reviewed the results of the CATT study, designed to compare two drugs Lucentis (ranibizumab) and Avastin (bevacizumab) used to treat wet AMD.
The inaugural Macular Degeneration Foundation Research Grants Program awarded nearly three-quarters of a million dollars to support crucial macular disease research.
The 2011 Eyes on the Future report provides the most comprehensive compilation of macular degeneration statistics and research ever undertaken in Australia.